Ligand validation:2YP9

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2YP9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YP9_NAG_A_1063	35%	65%	0.123	0.809	0.51	0.84	-	-	0	0	100%	0.9333
2YP9_NAG_A_1285	31%	54%	0.127	0.794	0.72	1.05	1	1	0	0	100%	0.9333
2YP9_NAG_A_1038	30%	60%	0.137	0.796	0.38	1.13	-	1	0	0	100%	0.9333
2YP9_NAG_A_1133	4%	49%	0.204	0.587	0.77	1.17	-	1	0	1	100%	0.9333
2YP9_NAG_A_1126	2%	50%	0.171	0.447	0.65	1.27	-	2	0	0	100%	0.9333
8FAW_NAG_A_601	73%	34%	0.115	0.941	0.67	1.92	-	4	1	0	100%	0.9333
4WE8_NAG_A_608	64%	57%	0.152	0.95	0.49	1.14	-	1	0	0	100%	0.9333
8FAQ_NAG_A_602	52%	61%	0.151	0.907	0.43	1.05	-	1	0	0	100%	0.9333
2YP2_NAG_A_804	50%	61%	0.104	0.853	0.48	1	-	1	0	0	100%	0.9333
2YP7_NAG_A_802	50%	66%	0.103	0.851	0.41	0.88	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.